A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
Aaron Y. Chang(Memorial Sloan Kettering Cancer Center), David A. Scheinberg(Memorial Sloan Kettering Cancer Center)
Cited by 92
Related Papers
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
|Cancer Discovery|2020|159
Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization
|PLoS ONE|2007|48
Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
|Cancer Immunology Immunotherapy|2023|34
Host Interactions with Engineered T-cell Micropharmacies
|Cancer Immunology Research|2023|5